Indications 
Dacfast™ P is indicated for mild to moderate pain associated with inflammation.
         
Contraindications
Dacfast™ P is contraindicated in patients with hypersensitivity to any of the ingredients, in those known to have bronchospasm or acute rhinitis or urticaria with aspirin or similar agents, presence of active or suspected peptic ulcer, gastrointestinal or other active bleeding, bleeding disorders, severe heart or kidney or liver failure. It is not advocated in small children below 18 months of age, & during the last trimester of pregnancy.

Aceclofenac (in Dacfast™ P) should be co-administered with caution along with oral thrombolytics, diuretics, cyclosporine, tacrolimus, phenytoin, digoxin, cimetidine, tolbutamide, phenylbutazone, amiodarone, miconazole, sulfaphenazole, methotrexate, lithium, and highly proteinbound drugs.
 
Drug Interactions
Aceclofenac (in Dacfast™ P) could interact with oral thrombolytics, diuretics, cyclosporine, tacrolimus, phenytoin, digoxin, cimetidine, tolbutamide, phenylbutazone, amiodarone, miconazole, sulfaphenazole, methotrexate, lithium, and Highly protein-bound drugs.

Dosage & Administration
ADULTS: 1 Dacfast™ PTab bid, or as prescribed.

Presentations
Dacfast™ P Tablets: Blisters of 10s.